L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl-

Request For Quotation
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- Suppliers list
Company Name: Shanghai Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: Jilin Chinese Academy of Sciences-yanshen Technology  
Tel: 18143011203
Email: ET-market@chemextension.com
Company Name: Shandong Dayou Pharmaceutical Research and Development Co., Ltd.  
Tel: hanfangpharma@126.com 15165037910
Email: hanfangpharma@126.com
Company Name: YJ Pharma  
Tel: 13962794339
Email: Sales@yucarepharma.com
Company Name: Henan Rane Chemical Co., Ltd.  
Tel: +86-18738066252
Email: info@ranechem.com
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- Basic information
Product Name:L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl-
Synonyms:L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl-;Hemiasterlin (SC209);SC209
CAS:1977557-86-0
MF:C27H44N4O4
MW:488.66
EINECS:
Product Categories:
Mol File:1977557-86-0.mol
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- Structure
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- Chemical Properties
Boiling point 705.0±60.0 °C(Predicted)
density 1.091±0.06 g/cm3(Predicted)
pka4.68±0.19(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- Usage And Synthesis
UsesSC209, an ADC cytotoxin extracted from patent WO2021247798, is used in synthesis of anti-EGFR antibody-drug conjugate ADC. SC209 is the payload of STRO-002[1][2].
References[1] Alice Yam, et al. Bispecific antibody-drug conjugates targeting egfr and muc1 and uses thereof. Patent. WO2021247798.
[2] De Almeida V, et al. Preclinical activity and safety of STRO-002, a novel ADC targeting folate receptor alpha for ovarian cancer. Gynecologic Oncology, 2018, 149: 50.
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- Preparation Products And Raw materials
Tag:L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl-(1977557-86-0) Related Product Information
L-Valinamide, 3-amino-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-3-carboxy-1-(1-methylethyl)-2-buten-1-yl]-N,3-dimethyl- L-Valinamide, 3-amino-N-[(1,1-dimethylethoxy)carbonyl]-N,β,β-trimethyl-L-phenylalanyl-N-[(1S,2E)-4-ethoxy-3-methyl-1-(1-methylethyl)-4-oxo-2-buten-1-yl]-N,3-dimethyl- Taltobulin (trifluoroacetate) TANDUTINIB Taltobulin (hydrochloride) (R)-Taltobulin